Evaluación de un programa de Atención Farmacéutica en pacientes con diabetes mellitus tipo 2

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorMaidana, G. M.-
Autor(es): dc.creatorLugo, G. B.-
Autor(es): dc.creatorVera, Z.-
Autor(es): dc.creatorPérez, S.-
Autor(es): dc.creatorMastroianni, P. C.-
Data de aceite: dc.date.accessioned2021-03-11T00:39:29Z-
Data de disponibilização: dc.date.available2021-03-11T00:39:29Z-
Data de envio: dc.date.issued2018-12-11-
Data de envio: dc.date.issued2018-12-11-
Data de envio: dc.date.issued2016-01-01-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/172575-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/172575-
Descrição: dc.descriptionIntroduction: Pharmaceutical Care is the responsible provision of pharmacotherapy for the purpose of achieving concrete results in order to improve the quality of life of patients. Objective: To evaluate the impact of pharmaceutical intervention in patients with Type 2 Diabetes Mellitus. With this aim, the following aspects were analyzed at the beginning and at the end of the study: glycemia, glycosylated hemoglobin, quality of life of the patients, their diabetes knowledge, current medications and initial medicine-related problems and the ones that were solved during the study. Methodology: It was carried out a random clinical trial in which some variables were measured before and after it. It was a non probabilistic and conveniently trial. 32 patients of the intervention group and 32 at a control group participated on it. Monthly interviews were performed in a period of 6 months of pharmaceutical intervention (from October 2011 to June 2012). In this period, only 3 dropouts were recorded. Results: The age of the patients was 55.6±10.6 years. The patients of the intervention group improved glycemia in 34%; 24 patients showed a value of (? 130 mg/dL); glycosylated hemoglobin improved in 1.9%; 15 patients reached the desired parameters (≤ 6.5%). The life quality of the intervention group increased from 56.3 to 71.3%. On the contrary, in the control group it decreased from 57.4 to 46.1 %.Within the intervention group were found 80 drug-related problems in 27 patients. 59 were solved. At the end of the research, 12 patients solved all their drug-related problems. 254 pharmaceutical interventions were performed. The level of patients' knowledge related to their disease improved by 41% and the knowledge about their medication improved by 53%. Conclusion: It was demonstrated that pharmaceutical interventions helped improving the life quality, the clinical parameters of glycemia, glycosylated hemoglobin and the use of medicines. On the other hand, they lowered drug-related problems and increased patients' satisfaction.-
Formato: dc.format3-15-
Idioma: dc.languagees-
Relação: dc.relationPharmaceutical Care Espana-
Relação: dc.relation0,107-
Direitos: dc.rightsclosedAccess-
Palavras-chave: dc.subjectPharmaceutical care-
Palavras-chave: dc.subjectPharmaceutical intervention-
Palavras-chave: dc.subjectType 2 diabetes mellitus-
Título: dc.titleEvaluación de un programa de Atención Farmacéutica en pacientes con diabetes mellitus tipo 2-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.